Proclemer A, Gradnik R, Savonitto S, Feruglio G A
Institute of Cardiology, Ospedale Civile, Udine, Italy.
Eur Heart J. 1987 Dec;8 Suppl M:81-5. doi: 10.1093/eurheartj/8.suppl_m.81.
The aim of this study was the electrophysiological evaluation of bisoprolol, a new highly cardioselective beta blocker, void of intrinsic sympathomimetic activity and without significant membrane stabilizing action. 10 patients (4 males and 6 females, mean age 67.5 years) with cardiac arrhythmias or syncopes of undetermined origin underwent His bundle recording with incremental as well as programmed atrial and ventricular pacing in an electrophysiological study. Electrophysiological parameters were measured at basal conditions and at 15 and 30 minutes after the infusion of bisoprolol 5 mg (for patient 1 to 5) and 10 mg (for patient 6 to 10). All electrophysiological parameters were within normal range at basal evaluation. Bisoprolol prolongs significantly sinus cycle length, corrected sinus node recovery time, AH interval, cycle length inducing AV-node block, effective and functional refractory periods of the AV-node. All these parameters remained within normal limits and were modified to about the same extent by 5 and 10 mg of the drug. No drug-related changes of QT interval were observed. Bisoprolol have been confirmed to have strictly beta-blocking properties.
本研究旨在对一种新型高心脏选择性β受体阻滞剂比索洛尔进行电生理评估,该药物无内在拟交感活性且无明显膜稳定作用。10例患有不明原因心律失常或晕厥的患者(4例男性,6例女性,平均年龄67.5岁)在电生理研究中接受了希氏束记录,并进行了递增以及程控心房和心室起搏。在基础状态下以及输注5 mg比索洛尔(用于患者1至5)和10 mg比索洛尔(用于患者6至10)后的15分钟和30分钟测量电生理参数。在基础评估时,所有电生理参数均在正常范围内。比索洛尔显著延长窦性周期长度、校正窦房结恢复时间、AH间期、诱发房室结阻滞的周期长度、房室结的有效和功能不应期。所有这些参数均保持在正常范围内,且5 mg和10 mg药物对其的改变程度大致相同。未观察到与药物相关的QT间期变化。已证实比索洛尔具有严格的β受体阻滞特性。